Trial intelligence / Profile preview

Perioperative Amino Acids for Renal Protection in Liver Transplantation

NCT07004387Not yet recruiting

Sponsor
Hospital Dr. Sótero del Río
Start
May 2025
Primary completion
May 2026
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of aminoven in acute kidney injury (AKI) (2 arms), sponsored by Hospital Dr. Sótero del Río. Primary endpoints: Occurrence of acute kidney injury according to KDIGO criteria at 10 days and Initiation and duration of renal replacement therapy at 10 days. Planned start May 2025; status: not yet recruiting.

02

Drugs

aminoven
03

Conditions

acute kidney injury (AKI)

Beyond the preview

Go deeper on NCT07004387.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07004387.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call